Research Center of Physiology, Semnan University of Medical Sciences, Semnan, Iran.
Faculty of Engineering and Natural Sciences, Sabanci University, Istanbul, Turkey.
Adv Exp Med Biol. 2021;1328:523-530. doi: 10.1007/978-3-030-73234-9_37.
With an increasing incidence of diabetes mellitus globally due to various factors, including unhealthy lifestyle, there is a need for developing novel drugs for the management of diabetes. This chronic metabolic disorder results in high blood glucose levels due to the body's inability to reduce the concentration of glucose. The decreased secretion of insulin and increased resistance to insulin action contribute to the development of diabetes mellitus. There have been efforts to target pathways involved in the metabolism of blood glucose. It seems that most of the currently applied antidiabetic medications are associated with unwanted side effects. Hence, it appears that plant-derived chemicals can be considered as potential candidates in the management of diabetes. Sodium-glucose cotransporter inhibitors (SGLT2i) are synthetic hypoglycemic medications approved for managing patients with diabetes in lowering blood glucose. SGLT2i reduces blood glucose concentration by enhancing its urinary excretion and inhibition of its absorption through the kidney. It has been demonstrated that some of the naturally occurring nutraceutical agents can imitate the action of SGLT2i and, consequently, diminish the level of blood glucose. At the present review, we have discussed the phytochemicals that act like SGLT2i to decrease blood glucose level.
由于不健康的生活方式等多种因素,全球糖尿病发病率不断上升,因此需要开发新型药物来治疗糖尿病。这种慢性代谢性疾病会导致血糖水平升高,因为身体无法降低葡萄糖的浓度。胰岛素分泌减少和胰岛素作用抵抗导致糖尿病的发生。人们一直在努力针对参与血糖代谢的途径。目前应用的大多数抗糖尿病药物似乎都存在不良副作用。因此,植物源性化学物质似乎可以被认为是糖尿病治疗的潜在候选药物。钠-葡萄糖共转运蛋白抑制剂(SGLT2i)是一种用于降低血糖的合成降血糖药物,已被批准用于治疗糖尿病患者。SGLT2i 通过增强其尿排泄并抑制肾脏吸收来降低血糖浓度。已经证明,一些天然存在的营养药物可以模拟 SGLT2i 的作用,从而降低血糖水平。在本综述中,我们讨论了作用类似于 SGLT2i 的植物化学物质,以降低血糖水平。